Jansspharma SPRL
2.8 FTEJansspharma reported total assets of €1.31m at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Aug 2026), with 2.8 full-time equivalents.
The score of Jansspharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +72 % Total assets +46 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Jansspharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Aug 2026
- Year ended 31 Dec 2024filed on 25 Aug 2025
- Year ended 31 Dec 2023filed on 30 Sep 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 30 Aug 2022
Jansspharma's financial analysis
- Solvency86.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Jansspharma
Jansspharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0897.420.541
- VAT number
- BE0897420541
- Peppol
- Registered · 0208:0897420541 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 22 Apr 2008
- Registered office
- 9520 Sint-Lievens-Houtem
- Size
- Micro · 2.8 FTE
- Latest accounts
- 2025 · filed on 29 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Jansspharma (SPRL) has been based in Sint-Lievens-Houtem since 2008, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 239,031 € and equity of €1.14m; its revenue is not published. With 2.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 86.8%, above the median of its sector (44.2%).
Companies similar to Jansspharma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek DE Pril K Retail sale of pharmaceutical products Merchtem · balance sheet €1.31m
- Apothekers MARIABURG Brasschaat Retail sale of pharmaceutical products Brasschaat · balance sheet €1.32m
- Pharmacie Blaes Retail sale of pharmaceutical products Brussels · balance sheet €1.31m
- Dorothea Retail sale of pharmaceutical products Erpe-Mere · balance sheet €1.32m
- APO-Pharman Retail sale of pharmaceutical products Alveringem · balance sheet €1.31m
- Minnen-Luyten Retail sale of pharmaceutical products Herentals · balance sheet €1.31m
- Apotheker Neyt Retail sale of pharmaceutical products Bruges · balance sheet €1.30m
- Apoteek Slachmuylders-Morias Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet €1.30m
Frequently asked questions about Jansspharma
What is the revenue of Jansspharma?
Jansspharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Jansspharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0897420541 for Jansspharma, if the company is VAT-registered. Its company number (CBE) is 0897.420.541.
Where is the registered office of Jansspharma?
According to the CBE register, the registered office of Jansspharma is in 9520 Sint-Lievens-Houtem.
What is the equity of Jansspharma?
At the close of the 2025 financial year, the equity of Jansspharma amounts to 1,141,581 €, a solvency of 86.8% of total assets.
How many people work at Jansspharma?
2.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Jansspharma?
The register lists 1 active mandates at Jansspharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Jansspharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →